Open access
Aug 2026
Integrated bioinformatics and molecular docking identify novel key genes, pathways, and potential candidate drugs in papillary thyroid carcinoma
The findings of the current study offer that FN1, DPP4, CD36, KIT, ITGA2 and hsa-miR-124-3p may be novel biosignatures and therapeutic targets for PTC.
Mehdi Koushki, M. Farahani, Nasrin Amiri-Dashatan et al.
· Journal of Genetic Engineeri... · 0 citations